Hepatitis C News

The Chinese Food and Drug Administration added Ascletis’ hepatitis C NS5A inhibitor ravidasvir to the list of proposed priority review to accelerate its new drug application process, according to a press release.

This year at the American College of Gastroenterology Annual Meeting, several hepatology specialists discussed the changing landscape of liver disease health care, such as increasing rates of nonalcoholic fatty liver disease which is quickly becoming the number one indication for liver transplantation.

The Canadian Minister of Health announced that the Government of Canada will fund 28 projects across the country designed to reduce the risk for bloodborne infections, such as hepatitis C and HIV, among people who use injection drugs, according to a press release.

PHILADELPHIA — Early detection of liver-related complications and hepatic diseases in patients who are pregnant leads to reduced risks and improved outcomes for both mother and child, according to a presentation at the American College of Gastroenterology Annual Meeting.

Experts in a recent review stated that an effective hepatitis C vaccine is critical for significant global control of the infection in combination with increased screening and treatment.

SAN FRANCISCO — Approximately one-third of teenagers and young adults with recorded opioid use disorders are screened for hepatitis C infection, according to research presented at IDWeek 2018. Researchers said that only a small portion of these patients are also screened for HIV.

Researchers found that both donation and use of hepatitis C-positive livers has steadily increased over the last couple years due to a significant number of livers from younger individuals related to the rise of drug overdose-related deaths, according to a recently published study.

Gilead Sciences announced plans to launch authorized generic versions of Epclusa and Harvoni, according to a company press release.

Details from a recently published review discussed expanded use of alcohol use disorder medications and treatments in everyday clinical practice for patients with advanced liver disease.

Risk for developing diabetes after undergoing kidney transplantation increased more than threefold for adults with presurgical hepatitis C infection vs. those with hepatitis B and those without infection, according to study results from researchers in China.